Comparative Studies on Pharmacopoeial Definitions, Requirements and Information for Crude Drugs among FHH Member Countries in 2007

Similar documents
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE

EVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL TEXTS FOR USE IN THE ICH REGIONS ON DISINTEGRATION TEST GENERAL CHAPTER Q4B ANNEX 5(R1)

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE

Good pharmacopoeial practices: Chapter on monographs on herbal medicines

2. Selection criteria for substances of herbal origin relevant for standardization and quality control of herbal medicines 77

Essential Medicines. WHO

Global review of the challenges in use of traditional medicine and WHO perspective

Traditional Chinese Medicine Forum

International Classification of Traditional Medicine: ICTM

Seventh Joint IAEA GIF Technical Meeting/Workshop on the Safety of Liquid Metal Cooled Fast Reactors

GOOD PHARMACOPOEIAL PRACTICES

Recognized Pharmacopoeia in Registration system

AGREEMENT ON COMMON PRINCIPLES AND RULES OF CIRCULATION OF MEDICINAL PRODUCTS WITHIN THE EURASIAN ECONOMIC UNION. (Moscow, 23 December 2014)

GOOD PHARMACOPOEIAL PRACTICES Draft chapter on monographs on herbal medicines

AD HOC WORKING GROUP ON HERBAL MEDICINAL PRODUCTS

IPEC Japan Update. Keiji Kijima Ph.D. Feb. 6 th, 2015 Hotel Negresco Nice (France)

::Contents:: IPEC Japan Update. 1. Self-imposed Standards of Excipient GMP Self-imposed Standards of Excipient GMP 2014

QUALITY OF HERBAL REMEDIES

Guideline on quality of herbal medicinal products 1 /traditional herbal medicinal products

Bi-weekly Influenza Situation Update

Discussion by HMPC Drafting Group on Quality February Start of public consultation 27 June 2012

Secretariat, Joint FAO/WHO Food Standards Programme, Codex Alimentarius Commission Viale delle Terme di Caracalla Rome, Italy

PROJECT DOCUMENT. Cooperative Agreement for Preventing the Spread of Communicable Diseases through Air Travel (CAPSCA)

Influenza Situation Update

Bi-weekly Influenza Situation Update

Bi-weekly Influenza Situation Update

Measuring Emissions as Part of a Regulatory Regime. Prof. Riccardo Polosa Professor of Internal Medicine and Convenor CEN TC437/WG4

Formulation stability studies. 9.1 OBJECTIVE To monitor the stability of the developed herbal formulations using the limited and specific methods.

APMP TCQM Activities. APMP EC-TCC meeting 3 November 2015, Beijing Euijin HWANG, APMP TCQM Chair

Guideline on the use of the CTD format in the preparation of a registration application for traditional herbal medicinal products 1

Bi-weekly Influenza Situation Update

HIV / AIDS & HUMAN RIGHTS

Influenza Situation Update

INTERNATIONAL HEALTH REGULATIONS

Indian Pharmacopoeia Commission

Influenza surveillance summary

Homeopathic medicinal products: an Update

Bi-weekly Influenza Situation Update

State Pharmacopoeia of Ukraine

Influenza Situation Update

REGIONAL ALLIANCE FOR NATIONAL REGULATORY AUTHORITIES FOR VACCINES IN THE WESTERN PACIFIC. second edition

SARS Epidemiology for Public Health Action

Influenza Situation Update

General Concepts in the European Pharmacopoeia. Anne-Sophie Bouin European Pharmacopoeia Department, EDQM, Council of Europe

Influenza Situation Update


The Trilateral FTA: A Pillar of Trilateral Cooperation and East Asia Economic Integration

WHITE PAPER ACCESS TO GOOD QUALITY DIETARY SUPPLEMENTS

Western Pacific Regional Office of the World Health Organization.

Kazuhiko Mori Ministry of Health, Labour and Welfare

CODEX Committee on Food Additives (CCFA) and the Codex General Standard for Food Additives (GSFA)


The State Pharmacopoeia of the Russian Federation

Fang-Chi Chang (M.D.,Ph.D.) Center for Drug Evaluation, Taiwan

Influenza Situation Update

ON SHELF AVAILABILITY ALIGNMENT PROJECT 2011 ASIA PAC SURVEY RESULTS

Promotion of Regulatory Cooperation Perspectives from the International Regulatory Cooperation for Herbal Medicines (IRCH)

GLP Update and Hot Topics

Western Pacific Regional Office of the World Health Organization

Food additives. FAO guidelines on the structure and content of the document called "Chemical and Technical Assessment (CTA)" Rome, February 2003

Analysis of Japanese Import Rejections of Asian Agri-food Products

Discussion at the HMPC January March Draft agreed by Quality Working Party April Adoption by CHMP for release for consultation 26 May 2005

Public Assessment Report Scientific discussion. Ginsana, soft capsule. Asp.no.:

Guideline on the use of the CTD format in the preparation of a registration application for traditional herbal medicinal products 1

Guideline on quality of herbal medicinal products 2 /traditional herbal medicinal products

3. CONCLUSIONS AND RECOMMENDATIONS

in the ICH Regions Table of Content Annexes to Guideline and 3. Why is Q4B necessary? Q4B Annexes? for Human Use

The International Pharmacopoeia - Overview

BRIEFING. Pharmacopeial Discussion Group Sign Off Document Attributes EP JP USP Definition Identification B Identification C + + +

Progress with GF-TADs in Asia and the Pacific Region

Joint Statement of The Tenth China-Japan-Korea Tripartite Health Ministers' Meeting (THMM)

Research on the Administrative Rules of APIs, Pharmaceutical Excipients and Auxiliary Materials Master File. Translation version

REPORT FROM THE AD HOC WORKING GROUP ON HERBAL MEDICINAL PRODUCTS 1997/1998

How to avoid common problems in research and manuscripts Dr. Bill Summerskill Senior executive editor, The Lancet

News Letter. Thanks letter AOCC2014. Asian Organization for Crohn s and Colitis. Vol.1 - Issue 1. Dear Colleagues, Dear Participants,

The Regional GF-TADs Progress Report

Safety issues in the preparation of homeopathic medicines

Scientific and Regulatory Basis for Development, Quality Assurance and Marketing Authorisation

Expert Advisory Group (EAG): Herbal and Complementary Medicines (HCM) BRITISH PHARMACOPOEIA COMMISSION

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

Japanese, Korean and Chinese subjects had also lived outside their respective countries for less than 10 years.

ASEAN GUIDELINES ON LIMITS OF CONTAMINANTS FOR TRADITIONAL MEDICINES (TM) AND HEALTH SUPPLEMENTS (HS)

Use and Perception of Scientific Medical Reprints

The Influence of Health and Beauty Perception on Medical Tourism Intentions: A Learning Lesson from Korea for Hong Kong

Industry and globalisation of herbal medicines

Survey on Current Situation of HIV/AIDS Control and Prevention for Foreigners in Tokyo

Economic and Social Council

Table 1. Measles case classification and incidence by country and area, WHO Western Pacific Region,

Organisations and/or individuals

Agenda. The current state of Pharmaceutical Excipients in Japan -JPE, JP, DMF, GAB (GMP Auditing Board)- Pharmaceutical Excipients

Consultation Document

Discussion by HMPC Drafting Group on Quality September Start of public consultation 15 February 2013

FMD STATUS AND CONTROL STRATEGY IN JAPAN

SUMMARY ASEAN+3 FETN VIDEO CONFERENCE 10 th November 2017

Committee of Senior Representatives Tenth Meeting Oslo, Norway 11 December 2006

Caring for the Southeast Asian Patient. Who Are they?

WORKABLE REGULATORY FRAMEWORK EUROPEAN PARLIAMENT, BRUSSELS 9 NOVEMBER 2016

General concepts in the Ph. Eur.: theory and rationale

Thomas Kemetmüller The Theory and Empirics of Financial Development in the East Asian Bond Markets 45

Transcription:

Comparative Studies on Pharmacopoeial Definitions, Requirements and Information for Crude Drugs among FHH Member Countries in 2007 (Reorganized edition with explanatory notes of tables) The Sub-Committee I of the Western Pacific Regional Forum for the Harmonization of Herbal Medicines (FHH) March 2011

.

Preface The Sub-Committee I meeting of the Western Pacific Regional Forum for the Harmonization of Herbal Medicines (FHH) on nomenclature and standardization was held at National Institute of Health Sciences, Tokyo, Japan, on 21-23 May. Representatives attended it from China, Hong Kong (China), Japan, Republic of Korea, Singapore and Vietnam. In the meeting the all participants recognized the importance of comparison on descriptions for herbal medicines in member party s pharmacopoeias or monograph standards as first step for the harmonization of nomenclature and standardization, and agreed to set up five expert working groups (EWG) for specific tasks as follows: 1. Nomenclature (Head: Eiji Sakai): The task was to prepare a comparison table on names of medicinal plant materials in CP, JP, KP and VP. 2. Testing Method in Monographs (Head: Nobuo Kawahara): The task was to list out the testing methods in monographs. The priority should be given to those medicinal plant materials appeared in all related four pharmacopoeias. 3. List of Chemical Reference Standards (CRS) and Reference of Medicinal Plant Materials (RMPM). (Head: Hiroyuki Fuchino: The task was to prepare a list of CRS and RMPM available in member parties. 4. List of Analytically Validated Method (Head: Yukihiro Goda): The task was to prepare a list of analytically validated methods in CP, JP, KP and VP. 5. Information on General Test (Head: Keum-ryon Ze, Jim-Sook Kim): The task was to collect information on general testing methodology on contamination such as pesticides, insecticides, herbicides, toxic metals and de-colouring agent in all member parties and to draft a report on testing methodology on contamination of different types of contaminants. Until August of 2007, the EWG members made a lot of efforts to fulfill the task described above. Almost all of the comparative tables or lists were available. At the Standing Committee meetings in Tokyo (2005 and 2006), the Sub-Committee I reported the data collected and prepared by the EWGs. This publication was compiled one of the reported data with additional information. The purpose of the publication entitled as Comparative Studies on Pharmacopoeial Definitions, Requirements and Information for Crude Drugs among FHH Member Countries in

2007 is primary to promote harmonization in the use of herbal medicines. The fist step of the harmonization is the mutual understanding of regulating system among member parties and Pharmacopoeia is the basis of the drug regulation. Therefore, we strongly expect that the publication will help the FHH members to achieve common consensus on herbal medicines. The convenor of the Sub-Committee I Motoyoshi SATAKE (Chair) Yukihiro GODA Edited by Nobuo KAWAHARA

Content Introduction 1 Section 1. Table 1-3 complied by expert working groups (EWG) I for Nomenclature 3 1 Comparative table on names of crude drugs in JP, CP, KP and VP 5 2 Comparative table on description of crude drugs in JP, CP, KP and VP 23 3 Comparative table on English titles and part of use of crude drugs in JP, CP, KP and VP 31 Section 2. Table 4-6 complied by EWG II for Testing Method in Monographs 39 4 Comparative table on testing methods and specification values for crude drugs in CP, JP, KP and VP 41 5 Comparative table on TLC conditions of identification for crude drugs in CP, JP, KP and VP 51 6 Comparative table on assay conditions for crude drugs in CP, JP, KP and VP 59 Section 3. Table 7-13 complied by EWG III for Lists of CRS and RMPM 65 7 List of CRS in Japanese pharmacopoeia 67 8 List of reference sample in JP 71 9 List of CRS in Korean Pharmacopoeia 77 10 List of CRS in Vietnamese Pharmacopoeia 83 11 List of Reference of Medicinal Plant Materials (RMPM) in CP 87 12 List of Reference of Medicinal Plant Materials (RMPM) in KP 93 13 List of Reference of Medicinal Plant Materials (RMPM) in VP 97 Section 4. Table 14-15 complied by EWG IV for Analytically Validated Methods 101 14 Analytically validated chemical assay, identification test and purity test for herbal materials in JP15 103 15 Analytically validated chemical assay or purity test for herbal materials in KP 107 Section 5. Table 16 complied by EWG V for Information on General Test 111 16 Comparative table on general testing methods for crude drugs in JP, KP, CP and VP 113 Acknowledgments 125

.